Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019
Dr. Peoples’ presentation is titled “The Yield10 Trait Factory: Deploying Knowledge Gained from Industrial Biotech with Genome-editing to Increase Crop Yield” and will take place on the ABLC Advanced Nutrition & Bioeconomy Feedstocks and Supply Chain track in a panel entitled “Advanced Yields through Technology” on
Dr. Peoples will describe the approaches Yield10 is taking to increase seed yield, oil content and biomass in crops. He will also highlight the Company’s GRAIN technology platform and provide an overview of traits in development by Yield10, including traits potentially accessible through genome-editing and applicable to major crops including canola, corn, soybean, wheat and rice.
The ABLC conference hosts professionals in policy, finance, partnerships, world class R&D and effective scale-up, spanning major agricultural companies, heads of all the top agricultural trade associations, and key government agencies. The keynote speaker is Hon.
For more information about the company, please visit www.yield10bio.com.
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, the use of the Company’s technology to successfully identify targets and develop systems for increasing crop yield and the progress toward developing yield traits in crops by Yield10, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in
Managing Director, CORE IR
FischTank Marketing and PR
Source: Yield10 Bioscience, Inc.